97
Views
48
CrossRef citations to date
0
Altmetric
Article

Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation

, , , , , , , , & show all
Pages 590-605 | Received 13 Nov 2011, Accepted 16 Nov 2011, Published online: 20 Mar 2023

REFERENCES

  • Agami R, Bernards R. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102:55–66.
  • Alt JR, Cleveland JL, Hannink M, Diehl JA. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102–3114.
  • Ang XL, Wade Harper J. 2005. SCF-mediated protein degradation and cell cycle control. Oncogene 24:2860–2870.
  • Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812–821.
  • Barbash O, et al. 2008. Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68–78.
  • Bessho Y, et al. 2001. Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dev. 15:2642–2647.
  • Blain SW. 2008. Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 7:892–898.
  • Buckley MF, et al. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133.
  • Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511.
  • Diehl JA, Zindy F, Sherr CJ. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957–972.
  • Fukami-Kobayashi J, Mitsui Y. 1999. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2. Exp. Cell Res. 246:338–347.
  • Guo Y, et al. 2005. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24:2599–2612.
  • Ishida N, et al. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355–14358.
  • Kamura T, et al. 2004. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase. Nat. Cell Biol. 6:1229–1235.
  • Kim JK, Diehl JA. 2009. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 220:292–296.
  • Kozar K, et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477–491.
  • Lee TH, Perrem K, Harper JW, Lu KP, Zhou XZ. 2006. The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J. Biol. Chem. 281:759–768.
  • Lin DI, et al. 2006. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCFFBX4-αB crystallin complex. Mol. Cell 24:355–366.
  • Malumbres M, et al. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493–504.
  • Matsushime H, et al. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323–334.
  • Matsushime H, et al. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
  • Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713.
  • Meyerson M, Harlow E. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077–2086.
  • Motokura T, et al. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512–515.
  • Nakayama K, et al. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
  • Nakayama K, et al. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J. 19:2069–2081.
  • Nakayama K, et al. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6:661–672.
  • Nakayama KI, Nakayama K. 2006. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6:369–381.
  • Newman RM, et al. 2004. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J. Biol. Chem. 279:41504–41511.
  • Okabe H, et al. 2006. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS One 1:e128.
  • Pagano M, Theodoras AM, Tam SW, Draetta GF. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1627–1639.
  • Pawar SA, et al. 2010. C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc. Natl. Acad. Sci. U. S. A. 107:9210–9215.
  • Pontano LL, et al. 2008. Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Mol. Cell. Biol. 28:7245–7258.
  • Rappsilber J, Ishihama Y, Mann M. 2003. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75:663–670.
  • Santra MK, Wajapeyee N, Green MR. 2009. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459:722–725.
  • Shinozaki H, et al. 1996. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res. 2:1155–1161.
  • Sicinski P, et al. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
  • Solomon DA, et al. 2003. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J. Biol. Chem. 278:30339–30347.
  • Tsunematsu R, et al. 2006. Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development. Mol. Cell. Biol. 26:6157–6169.
  • Wang TC, et al. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
  • Wei S, et al. 2008. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J. Biol. Chem. 283:26759–26770.
  • Xu X, et al. 2008. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol. Cell 30:403–414.
  • Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. 1994. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol. 145:86–96.
  • Yu ZK, Gervais JL, Zhang H. 1998. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21CIP1/WAF1 and cyclin D proteins. Proc. Natl. Acad. Sci. U. S. A. 95:11324–11329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.